- Home
- ELTK vs VRCA Comparison
ELTK vs VRCA Comparison
Compare ELTK & VRCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELTK
- VRCA
- Stock Information
- Founded
- ELTK 1970
- VRCA 2013
- Country
- ELTK Israel
- VRCA United States
- Employees
- ELTK N/A
- VRCA N/A
- Industry
- ELTK Electrical Products
- VRCA Biotechnology: Pharmaceutical Preparations
- Sector
- ELTK Technology
- VRCA Health Care
- Exchange
- ELTK Nasdaq
- VRCA Nasdaq
- Market Cap
- ELTK 70.4M
- VRCA 58.7M
- IPO Year
- ELTK 1997
- VRCA 2018
- Fundamental
- Price
- ELTK $10.18
- VRCA $5.96
- Analyst Decision
- ELTK
- VRCA Hold
- Analyst Count
- ELTK 0
- VRCA 5
- Target Price
- ELTK N/A
- VRCA $60.00
- AVG Volume (30 Days)
- ELTK 9.3K
- VRCA 54.3K
- Earning Date
- ELTK 08-14-2025
- VRCA 08-12-2025
- Dividend Yield
- ELTK 1.87%
- VRCA N/A
- EPS Growth
- ELTK N/A
- VRCA N/A
- EPS
- ELTK 0.45
- VRCA N/A
- Revenue
- ELTK $49,563,000.00
- VRCA $14,704,000.00
- Revenue This Year
- ELTK $18.60
- VRCA $165.25
- Revenue Next Year
- ELTK $9.04
- VRCA $80.06
- P/E Ratio
- ELTK $22.55
- VRCA N/A
- Revenue Growth
- ELTK 6.75
- VRCA 5.72
- 52 Week Low
- ELTK $7.65
- VRCA $3.82
- 52 Week High
- ELTK $12.19
- VRCA $34.30
- Technical
- Relative Strength Index (RSI)
- ELTK 46.22
- VRCA 42.31
- Support Level
- ELTK $10.20
- VRCA $5.29
- Resistance Level
- ELTK $10.45
- VRCA $7.40
- Average True Range (ATR)
- ELTK 0.35
- VRCA 0.64
- MACD
- ELTK -0.01
- VRCA -0.01
- Stochastic Oscillator
- ELTK 27.94
- VRCA 31.75
About ELTK Eltek Ltd.
Eltek Ltd is engaged in the technology business sector that manufactures and supplies technologically new custom-made circuitry solutions. It manufactures, markets, and sells custom-made printed circuit boards (PCBs), including high-density interconnect, flex-rigid and multi-layered boards. The Company markets its products mainly to the medical technology, defense and aerospace, industrial, telecom, and networking equipment industries. Its geographic areas are Israel, North America, the Netherlands, India, and Others. It generates the majority of its revenue from Israel.
About VRCA Verrica Pharmaceuticals Inc.
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.